High Intensity Focused Ultrasound (HIFU) Market Information: By Modality (Therapeutic Ultrasound, Hemostasis), By Method (Non-Invasive and Minimal-Invasive Method), By Application (Prostate Cancer, Uterine Fibroids, and others), By End Users (Diagnostic Centers, Hospitals, Research Centers) - Forecast till 2030

High Intensity Focused Ultrasound (HIFU) Therapy Market Overview

The global high intensity focused ultrasound (HIFU) therapy market is anticipated to reach USD 275.3 Million by 2030 at 15.50% CAGR during the forecast period 2022-2030. Ongoing technological improvements in the field of diagnostic and therapeutic ultrasound imaging, obtainability of medical indemnified for diagnostic ultrasound procedures in grown-up markets, and the rising uses of emerging ultrasound techniques are boosting the growth of the ultrasound or HIFU market. The effect of the covid-19 pandemic and the lockdowns it triggered is clearly visible in several markets, including the ultrasound market. However, last year, the overall growth of several sectors has been highly affected, especially countries with a high rising rate of covid-19, such as India, China, Brazil, the USA, and various European countries, that includes Spain, Russia, the UK, and Italy.

FIGURE 1 Global High Intensity Focused Ultrasound (HIFU) Therapy Market, by Applications, 2016 (%)

Source: World Health Organization, Centers for Disease Control and Prevention, European Society of Clinical Microbiology and Infectious Diseases, U.S. National Library of Medicine, National Organization for Rare Disorders, The American Autoimmune Related Diseases Association, The International Society for Human and Animal Mycology, Expert Interview Market Research Future Analysis, Annual report, White paper, Company Presentation

Key Players  Some of the key players in high intensity focused ultrasound (HIFU) therapy market are Image Guided Therapy, EDAP TMS, SonaCare Medical, LLC, Theraclion, Chongqing Haifu Medical Technology Co., Ltd, Koninklijke Philips N.V., Shanghai A&S Co. LTD, Mianyang Sonic Electronic Ltd., Insightec, Alpinion Medical Systems, and FUS Instruments.

Segments                                                          

The global high intensity focused ultrasound (HIFU) therapy market is segmented on the basis of modality, which comprises of therapeutic ultrasound, hemostasis, lithotripsy, thrombolysis, immunomodulation, and others.

On the basis of the methods, the high intensity focused ultrasound (HIFU) therapy market is segmented into non-invasive method, and minimal invasive method.

On the basis of applications, the high intensity focused ultrasound (HIFU) therapy market is segmented into prostate cancer, uterine fibroids, neurological disorders, cosmetic medicine, and others.

On the basis of end users, the high intensity focused ultrasound (HIFU) therapy market is segmented into diagnostic centers, hospitals, research centers, and others.

Regional Analysis The Americas accounts for the largest share in the global high intensity focused ultrasound (HIFU) therapy market. It includes North America and South America.  North America dominates the market due to growing prevalence of cancers in this region, which  is one of the major driving factors for the growth of high intensity focused ultrasound (HIFU) therapy market.

Europe is the second highest revenue generating region in the global HIFU therapy market. Europe is mainly consist of Eastern Europe and Western Europe. More developed countries of Western Europe such as Germany, France, and the UK are holding the major market share, whereas the Eastern European countries are also growing at a significant rate. Owing to developing healthcare infrastructure and increasing healthcare expenditure, and growing adoption of HIFU therapy for the treatment of cancers and related diseases drive the growth of the HIFU therapy market.

In Asia Pacific, increasing government support for research & development in healthcare domain, growing number of cancer cases drives the growth of the market.

The Middle East & Africa is expected to show a least market share due to less availability of medical facilities, and less development in healthcare domain.Recent Development

When industries like oil and petroleum, aeronautics, and the healthcare, biotechnologies, and pharmaceutical industries are concentrating on optimizing their applications to help a maximum number of patients and healthcare professionals. The market for ultrasound has been severely affected by the pandemic and this trend is projected to continue in rules, regulations, and guidelines are degrading the growth of the ultrasound market. The shutting down of manufacturing provisions due to lockdowns, disruptions in the supply chain, and recruitment challenges for clinical trials have again affected the growth of the overall global ultrasound market. The high and rising cases of target diseases and conditions will drive the adoption of productive diagnostic and therapeutic procedures. The ultrasound technologies are cost-efficient, safer, and offer earlier diagnostic and treatment of targeted disease administrative is projected to rise during the anticipated period. According to the American heart association’s analyst, by 2030, about 41.1% of adults will have hypertension and the number will increase.

Intended Audience

• High intensity focused ultrasound (HIFU) system/device supplies companies


• High intensity focused ultrasound (HIFU) system/device providers


• Research and development (R&D) companies


• Market research and consulting service providers


• Potential investors

Source: World Health Organization, Centers for Disease Control and Prevention, European Society of Clinical Microbiology and Infectious Diseases, U.S. National Library of Medicine, National Organization for Rare Disorders, The American Autoimmune Related Diseases Association, The International Society for Human and Animal Mycology, Expert Interview Market Research Future Analysis, Annual report, White paper, Company Presentation